Technology | Magnetic Resonance Imaging (MRI) | February 19, 2018

FDA Clears Siemens Healthineers' GOKnee3D MRI Application

Application reduces scan time for MR imaging of the knee and enables clinically validated, push-button isotropic 3-D knee exam with all relevant contrasts and evaluation in all imaging planes

FDA Clears Siemens Healthineers' GOKnee3D MRI Application

February 19, 2018 — The U.S. Food and Drug Administration (FDA) has cleared GOKnee3D, a magnetic resonance imaging (MRI) application from Siemens Healthineers that significantly reduces the time required to perform comprehensive diagnostic exams of the knee.

GOKnee3D enables a push-button diagnostic 3-D knee exam in just 10 minutes – a substantial reduction from the standard MR knee examination.[1] Acquisition of high-resolution isotropic 3-D images enables flexible evaluation of these images in all planes, including double oblique and curved planar.

The volume acquisition of GOKnee3D enables higher scan speeds and optimal image reconstruction with better signal quality than in previous technologies. Supported by dedicated, high-channel Tim 4G knee coils as well as automated field of view adaptation based on machine learning and artificial intelligence, the MRI scanner acquires volume data of the knee joint with the push of a button.

GOKnee3D is available for the Magnetom Aera 1.5T and the Magnetom Skyra 3T MRI scanners, with eventual rollout planned for additional scanners in the company’s MRI portfolio.

For more information: www.usa.healthcare.siemens.com

Related GOKnee3D Content

Siemens Healthineers Introduces GOKnee3D MR Application

VIDEO: Editor's Choice of the Most Innovative New Imaging Technology at RSNA 2017

Notes

1. Examination time for 3T systems is 10 minutes; for a 1.5T system, up to 11 minutes. All given examination times are examination only; adjustments have been excluded. Applies to measurements only with 15channel knee coil.

 

Related Content

Two magnetic resonance imaging (MRI) findings — joint capsule edema and thickness at the axillary recess, specifically — proved useful in predicting stiff shoulder in patients with rotator cuff tears, according to an ahead-of-print article in the May issue of the American Journal of Roentgenology (AJR)

A: Oblique coronal fat-suppressed T2-weighted MR image shows normal hypointense joint capsule at axillary recess (arrow). Note full-thickness tear of supraspinatus tendon (arrowheads) B: Oblique sagittal proton density MR image shows preserved subcoracoid fat triangle (asterisk). Image courtesy of the American Journal of Roentgenology (AJR)

News | Magnetic Resonance Imaging (MRI) | February 20, 2020
February 20, 2020 — Two ma...
Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Radiology Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
Hyperfine Research, Inc. announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the world’s first bedside Magnetic Resonance Imaging (MRI) system

Hyperfine's point-of-care MRI wheels directly to the patient’s bedside, plugs into a standard electrical wall outlet, and is controlled via a wireless tablet. Photo courtesy of Business Wire

News | Magnetic Resonance Imaging (MRI) | February 12, 2020
February 12, 2020 — Hyperfine Research, Inc. announced that i
The magnetic resonance imaging (MRI) contrast agents market is expected to grow rapidly

Image courtesy of GE Healthcare

News | Magnetic Resonance Imaging (MRI) | February 11, 2020
February 11, 2020 — The magnetic resonance imaging (MRI) contrast agents market is expected to grow rapidly in the fo
Gadolinium-based contrast agents

UT Dallas faculty members who collaborated with Dr. Jeremiah Gassensmith (center, back), associate professor of chemistry and biochemistry, include Dr. Lloyd Lumata (left, back), assistant professor of physics, and Dr. Steven Nielsen, associate professor of chemistry. Chemistry graduate students in Gassensmith’s lab include (from left, front) Oliva Brohlin, Arezoo Shahrivarkevishahi and Laurel Hagge.

News | Contrast Media | February 06, 2020
February 6, 2020 — University of Texas at Dallas researchers
Qynapse, a medical technology company, announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its QyScore software
News | Information Technology | February 04, 2020
February 4, 2020 — Qynapse, a medical technology company, anno
RSNA 2019

RSNA 2019

Feature | Radiology Imaging | January 31, 2020 | By Greg Freiherr
The founder of Gonzo journalism thought
This image is of an 80 kg woman with a newly diagnosed IDH-wildtype glioblastoma

This image is of an 80 kg woman with a newly diagnosed IDH-wildtype glioblastoma. The quarter dose image on the left was obtained after the administration of 4 ml of MultiHance. Subsequently, an additional 12 ml of MultiHance was administered and the cumulative full dose image in the center was obtained. The image on the right was rendered following artificial intelligence processing of the 4 ml image using eGad genetic algorithms. This image has the quality of triple dose gadolinium even though only one quarter dose gadolinium was given.

Feature | Contrast Media Injectors | January 30, 2020 | By Matthew Kuhn, M.D., FACR
Gadolinium-based contrast agents (...
The researchers used high resolution cross-sectional imaging with CT or MRI to assess 225 men with abdominal aortic aneurysm. Follow-up lasted, on average, more than three years.  Slightly more than half of patients had an intraluminal thrombus. The aneurysms of those with intraluminal thrombus were larger at baseline and grew by a rate of 2 mm per year, twice as fast as the 1 mm per year growth rate in people without intraluminal thrombus.
News | Computed Tomography (CT) | January 29, 2020
January 29, 2020 – The presence of a blood clot on the wall of the aorta in people with...